This article is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. TotalHealthRD.com is a health information website — not a medical practice. Nothing in this article should be used to adjust, stop, or substitute for any prescribed medication. Consult your healthcare provider or pharmacist before starting any supplement if you take prescription medications or have existing health conditions.
Medical Disclaimer: This safety guide covers documented drug interaction categories for CBD supplements. This information does not replace a conversation with your prescribing physician or pharmacist, who can assess interactions specific to your medication dosages and health history. Do not change or discontinue any prescription medication based on information in this article.
By TotalHealthRD.com Editorial Team
Quick Answer: CBD inhibits cytochrome P450 liver enzymes (CYP3A4, CYP2C9, CYP2D6) that metabolize a wide range of prescription medications. The result: those medications may accumulate to higher-than-intended blood levels, increasing effects or side effects. The highest-risk categories are anticoagulants (warfarin specifically), antiepileptics, sedatives and benzodiazepines, and certain antidepressants. Anyone on prescription medication in these or related classes should consult their physician before starting any CBD supplement.
Who This Safety Briefing Is For
This guide is for adults who are considering a CBD supplement and want to understand the interaction landscape before speaking with their physician. It covers the four medication classes with the most documented interaction potential, one condition-specific consideration (liver disease), and a practical framework for the physician conversation.
This guide is relevant to all CBD formats — gummies, oils, capsules, tinctures — not just products discussed elsewhere on this site. The interaction mechanism (CYP450 enzyme inhibition) is a property of cannabidiol itself, not a delivery-method-specific effect.
If you are not on any prescription medications and do not have liver, kidney, or other organ conditions, the interaction risk profile of CBD supplementation is generally considered lower for healthy adults. Even in that context, discussing any new supplement with your healthcare provider is a reasonable step, particularly for CBD given its evolving regulatory status.
Anticoagulants and Blood Thinners: The Highest-Priority Interaction
CBD inhibits CYP2C9, the primary enzyme responsible for metabolizing warfarin (brand name Coumadin). When CYP2C9 is inhibited, warfarin is broken down more slowly, and blood levels rise above the intended therapeutic range. Elevated warfarin levels increase bleeding risk — sometimes significantly.
Case reports documenting INR (international normalized ratio) elevation in patients on warfarin who added CBD exist in the published literature. A 2017 case report in Epilepsy and Behavior (Grayson et al., PMID: 28161625) documented significant INR elevation in a pediatric epilepsy patient on warfarin after starting pharmaceutical CBD. While this case involved pharmaceutical-dose CBD, the mechanism — CYP2C9 inhibition — is not dose-exempt at lower amounts.
Adults on warfarin or other anticoagulants including apixaban (Eliquis), rivaroxaban (Xarelto), and edoxaban should treat this interaction as a hard stop requiring physician consultation before CBD use. This is not an area where starting and monitoring casually is appropriate.
Antiepileptic Drugs: Bidirectional Interaction Risk
The antiepileptic drug class has the most extensively studied CBD interaction profile, primarily because Epidiolex — pharmaceutical CBD — is used as an add-on treatment for seizure disorders, and clinicians have systematically tracked drug-drug interactions in this context.
CBD inhibits CYP3A4 and CYP2C19, enzymes that metabolize several antiepileptic drugs. Clobazam (Onfi), a commonly used antiepileptic, is metabolized by CYP2C19. CBD co-administration in Epidiolex clinical trials increased clobazam and its active metabolite blood levels, which produced sedation in some patients and required dose adjustments. Valproic acid, another widely used antiepileptic, has been associated with elevated liver enzyme levels when combined with pharmaceutical CBD in some studies.
For adults on antiepileptic medications who are not under a physician's management for seizure disorders — for example, someone on an antiepileptic for pain or mood — the same interaction concerns apply. Physician consultation before starting CBD is required, not optional, in this category.
Sedatives and Benzodiazepines: Additive Effects
CBD has sedative properties at relevant doses and interacts with GABA receptors through indirect mechanisms. Combined with benzodiazepines (alprazolam, lorazepam, clonazepam, diazepam) or other central nervous system depressants, additive sedation is a plausible and documented concern.
Additionally, benzodiazepines are metabolized by CYP3A4, which CBD inhibits. This means benzodiazepine blood levels may rise when CBD is added — compounding the additive sedation risk with a pharmacokinetic elevation mechanism. For adults using benzodiazepines as-needed (such as for acute anxiety events), the timing of CBD and benzodiazepine use and any effects on alertness or coordination should be discussed with a prescriber before combining the two.
Non-benzodiazepine sleep aids (zolpidem, eszopiclone) are also metabolized by CYP3A4, and the same cautions apply.
Antidepressants: CYP2D6 and Serotonin Considerations
The antidepressant interaction with CBD has two components. First, CBD inhibits CYP2D6, which metabolizes several SSRIs (fluoxetine, paroxetine) and many tricyclic antidepressants. Inhibition slows breakdown, potentially elevating antidepressant blood levels. Second, CBD activates 5-HT1A serotonin receptors — the same receptor targeted by buspirone and partially relevant to SSRI mechanisms. While serotonin syndrome risk from CBD and SSRIs specifically is not well-documented in published case literature, the theoretical overlap in serotonergic activity warrants physician oversight when combining these agents.
Adults on any antidepressant medication should discuss CBD with their prescriber before starting. This includes SSRIs, SNRIs, tricyclics, and MAO inhibitors.
Liver Conditions: A General Caution
CBD is processed primarily by the liver. Adults with existing liver conditions — fatty liver disease, hepatitis, cirrhosis, or elevated liver enzymes from any cause — should approach CBD supplementation with physician guidance. At the pharmaceutical doses used in clinical trials, CBD has been associated with elevated transaminase levels in a subset of participants. At OTC gummy doses, this risk is lower but not absent, particularly in the context of pre-existing liver stress.
CBD also inhibits the same CYP450 enzymes that process many medications used for liver-related conditions, meaning the interaction risk in this population may be compounded.
General Safety Profile for Healthy Adults
For adults who are not on prescription medications and do not have significant organ conditions, the safety profile of CBD at OTC gummy doses is generally described as favorable in the published literature. A 2017 review in Cannabis and Cannabinoid Research (Iffland and Grotenhermen, PMID: 28861514) examined safety and tolerability data across human studies and concluded that CBD is well-tolerated, with a good safety profile, in a wide range of doses. Side effects in clinical trials have included diarrhea, changes in appetite, and fatigue, primarily at higher pharmaceutical doses.
For healthy adults, the considerations most relevant to CBD gummy use specifically are: drug testing risk from trace THC in full-spectrum products, pregnancy and breastfeeding (CBD should not be used during pregnancy or while nursing, per the FDA's consumer advice), and the evolving federal regulatory status covered in detail in the our review of Triple Green Farms CBD Gummies.
When to Consult a Physician Before Starting CBD
Consult a physician before starting CBD supplementation if any of the following apply: you take any prescription medications (especially from the categories above); you have a liver, kidney, or cardiovascular condition; you are pregnant, planning to become pregnant, or breastfeeding; you have a diagnosed psychiatric condition currently managed with medication; you have a personal or family history of liver enzyme abnormalities.
The most productive physician conversation about CBD includes: the specific product and per-serving dose you are considering, your current medication list including all prescription and OTC drugs, your intended reason for using CBD, and a request to check whether any of your current medications are metabolized by CYP3A4, CYP2C9, or CYP2D6.
A pharmacist can often provide a faster drug interaction check for specific medication combinations. This is an underutilized resource — most pharmacies will review a supplement against a medication list on request. For a deeper understanding of how CBD interacts with the endocannabinoid system, that article provides the mechanistic foundation. For product-specific information, the published CBD clinical research overview and the full-spectrum CBD gummies comparison provide additional context.
Frequently Asked Questions
Can CBD interact with blood pressure medication?
CBD can interact with certain blood pressure medications through CYP3A4 and CYP2C9 inhibition. When CBD inhibits these enzymes, blood pressure medication blood levels may increase, potentially intensifying effects or side effects. The specific interaction depends on which medication is involved. Adults taking any prescription blood pressure medication should consult their prescribing physician before starting CBD. This is the same enzyme pathway responsible for the grapefruit warning found on many cardiovascular medications — CBD can produce analogous interactions.
Is it safe to take CBD with antidepressants?
CBD can interact with several antidepressant classes through CYP2D6 inhibition, which slows breakdown of SSRIs and tricyclic antidepressants and may elevate their blood levels. CBD also activates 5-HT1A serotonin receptors, creating theoretical overlap with serotonergic medications. Anyone on antidepressant medication should discuss CBD use with their prescriber before starting — this applies to SSRIs, SNRIs, tricyclics, and MAO inhibitors.
Does CBD affect liver function?
CBD is processed by the liver and can inhibit liver enzyme activity (CYP450) at various doses. At high pharmaceutical doses, CBD has been associated with elevated liver enzymes in clinical trials. At OTC gummy doses, this risk is lower but not absent. Adults with existing liver conditions should consult a physician before starting CBD. Even for healthy adults, CYP450 inhibition remains a relevant consideration for drug interactions regardless of dose.
Can you take CBD if you are on warfarin or other blood thinners?
CBD inhibits CYP2C9, the primary enzyme metabolizing warfarin. This can raise warfarin blood levels and increase bleeding risk. Case reports of INR elevation in warfarin patients who added CBD are documented in the published literature. Adults on warfarin, apixaban, rivaroxaban, or other anticoagulants should not start a CBD supplement without physician consultation and a monitoring plan. This is among the highest-priority interactions in the CBD safety literature.
TotalHealthRD.com is an independent health information publication. Nothing published here constitutes medical advice. This is a traffic-first article — no affiliate links are present.